H2020-MSCA-RISE-2017 Project Nr. 777810 Project
MULTIFUNCTIONAL POLYMER COMPOSITES DOPED WITH NOVEL 2D NANOPARTICLES FOR ADVANCED APPLICATIONS
NANO2DAY MID-TERM CONTRACTUAL MEETING and Workshops,
28-31 MAY 2019
Venue: Polymer Institute Slovak Academy of Sciences Address: Dubravska cesta 9, 845 41, Bratislava, Slovakia
Mid-Term Contractual Meeting was aimed: to assess the general advancement of the project; to identify issues related to project implementation; to find the relevant solutions; to meet researchers seconded in the project; to make sure that all information provided to the PO before the meeting is accurate.
During the Meeting progress of the WP1-6 was presented by responsible partners and discussed by the consortium. Seconded persons presented their contribution to the WPs including scientific background (education/experience and home institution) and secondment details (period, tasks, impact both on the overall project and on his/her own career).

List of participants
RESEARCH EXECUTIVE AGENCY (REA)
1. Eleftheria Lykouressi
LATVIJAS UNIVERSITATE (LU)
2. Andrey Aniskevich
3. Sergejs Tarasovs
4. Olga Bulderberga
KAUNO TECHNOLOGIJOS UNIVERSITETAS (KTU)
5. Daiva Zeleniakienė
6. Gediminas Monastyreckis
LULEA TEKNISKA UNIVERSITET (LTU)
7. Roberts Joffe
USTAV POLYMEROV - SLOVENSKA AKADEMIA VIED (UPO)
8. Maria Omastova
9. Michal Procházka
10. Simona Procházková
11. Matej Mičušík
12. Anastasiia Stepura
13. Andrii Misiura
DANMARKS TEKNISKE UNIVERSITET (DTU)
14. Leon Mishnaevsky Jr.
BALTIC SCIENTIFIC INSTRUMENTS SIA (BSI)
15. Vladimir Gostilo
MATERIALS RESEARCH CENTER (MRC)
16. Oleksiy Gogotsi
17. Veronika Zahorodna
18. Vitalii Balitskyi
SYNPO AKCIOVA SPOLECNOST (SYNPO)
19. Vladimir Spacek
20. Dagmar Mazánková
UAB SPORTINE AVIACIJA IR KO (SA)
21. Stasys Skalskis
BELARUSIAN STATE UNIVERSITY (BSU)
22. Hanna Maltanova
DREXEL UNIVERSITY (DU)
23. Yury Gogotsi




MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
